Hengkang Medical Group Co Ltd002219
Mentioned
Impact on assets 1
Others
Hengkang Medical Group Co LtdTheme Impact 2
Off-coverage companies 1
山东泽普医疗科技有限公司Private▲ Positive
Capitalrelevance
Acquisition at high premium with valuation based on AI, embodied intelligence, BCI, and rehab robots.
Related news
United States▲2impact 4
Medtronic Raises Fiscal 2027 Guidance as Revenue Jumps 13.7%
Medtronic reported first-quarter fiscal 2027 revenue of $9.76 billion, up 13.7% from a year earlier, and raised its full-year outlook, with adjusted diluted EPS climbing 15.1% to $1.45 and GAAP EPS rising 40.7% to $1.14. Management now expects organic revenue growth of 7.25%-7.75% for fiscal 2027, up from 6.75%-7.25% previously, and lifted adjusted EPS guidance to $5.94-$6.00. The quarter included an extra selling week that added about $570 million to revenue, so the headline growth rate should not be expected to repeat. Cardiovascular delivered strong growth, while Neuroscience, Medical Surgical and Diabetes also posted high-single-digit or double-digit organic growth. At a share price of around $89-$90, the stock trades at roughly 15 times the midpoint of the adjusted EPS forecast, versus about 22 times trailing earnings, while paying a quarterly dividend of $0.72 per share, or $2.88 a year, for a yield of roughly 3.2%-3.3%. Medtronic is also expanding its Affera cardiac mapping and ablation system, investing in Pi-Cardia and Cornerstone Robotics, and has acquired Scientia Vascular and SPR Therapeutics, with a planned separation of its Diabetes business.
About megatrends
Aging Population › Medical Devices for the Aging Body ▲Demand
Robotics & Physical AI › Surgical & Medical Robotics ▲Demand
Biotech & Genomic Medicine › Diabetes Devices (CGM & Insulin Delivery) Demand
Brain-Computer Interface › Neuromodulation & Closed-Loop Neurostimulation Demand
MDT · Capital · Positive Medtronic raised fiscal 2027 guidance and posted 13.7% revenue growth with adjusted EPS up 15.1%, a financial/earnings event.
India
Japan
ChinaUnited StatesIntuitive Surgical Eyes India and Japan Growth to Offset China Weakness
Intuitive Surgical is leaning on expansion in India and Japan to counterbalance persistent headwinds in China, where only two da Vinci systems were placed in the second quarter. International da Vinci procedures rose 20% in the quarter, with Europe and Asia each delivering 20% growth, while China remained the primary regional drag due to lower tender activity, increased domestic robotic competition, policy-driven pricing pressure, changes in charge codes and the 15th Five-Year Plan quota process. Da Vinci 5 has yet to receive clearance in mainland China, but its clearance in India during the quarter should expand the company's ability to address demand with its latest-generation platform. In Japan, policies effective June 1 expanded reimbursement to additional robotic procedures and introduced economic incentives for higher utilization, and Intuitive Surgical placed 25 systems there versus 15 a year earlier, though adoption is expected to progress gradually given training requirements and ongoing financial challenges. Intuitive Surgical maintained its 2026 da Vinci procedure growth outlook of 13.5-15.5%, with international procedures outside urology among its primary growth drivers.
About megatrends
Robotics & Physical AI › Surgical & Medical Robotics Demand
ISRG · Competition · Negative Increased domestic robotic competition and policy-driven pricing pressure in China dragged on placements, with only two da Vinci systems placed in Q2
ISRG · Demand · Positive Da Vinci 5 cleared in India and Japan reimbursement expansion with 25 systems placed (vs 15) should expand procedure demand, offsetting China weakness
Japan▲
Japan poll shows 70% support using AI and robots in healthcare to address staffing crisis
Japan's Ministry of Health, Labour and Welfare revealed the findings of its annual white paper, showing that more than 70% of Japanese people have a positive attitude toward the use of advanced technologies such as artificial intelligence and robots in the medical and nursing care sectors. The online opinion survey found that 72.4% agreed or somewhat agreed with using AI to help doctors diagnose diseases, and 73.7% supported the use of robots to facilitate communication between caregivers and care recipients. At the same time, 74.5% said they felt or somewhat felt anxious about the shortage of healthcare workers, and 81.3% expressed similar concern about elderly care. The study underscores the importance of improving efficiency and raising productivity by adopting technology around 2040, when Japan's population aged 65 and over is expected to peak, amid a worsening shortage of doctors, nurses, and caregivers. The survey was conducted in January and February among people living in Japan aged 20 to 74, and received 3,000 complete responses.
About megatrends
Robotics & Physical AI › Surgical & Medical Robotics ▲Demand
Aging Population › Senior Care Technology